Explore Current Opportunities
The following offerings are being conducted under Regulation A, Regulation D, or Regulation CF through C2MSecurities, LLC (“C2M Securities”). C2M Securities is an affiliate of Capital2Market Technology, LLC, and a FINRA/SEC registered broker-dealer. Investments in alternatives involve a high degree of risk and those investors who cannot afford to lose their entire investment should not invest. Learn more about the risks of investing in alternatives and the nature of the venture asset class by looking at our general risk factors.
Applied Biological Laboratories
Investment in Series C Preferred Equity
- Investment in a high growth leader in the fast growing natural remedy biopharma industry.
- Award winning product -- Biovanta -- that has wide retail distribution in the United States and robust pipeline of promising drugs.
Investment in Class B Participating Preferred Equity
- Investment in the high growth industry of single family home build-to-rent real estate.
- Owner operated with experienced and entrepreneurial management team.
- 10% annual coupon with liquidation preferences.
Investment in Series A Participating Preferred
Our mission is to fundamentally change the nature of surgery and allow previously unimaginable surgical techniques in the most difficult-to-reach areas of the body. Join us to help bring the next generation of surgical technology to surgeons and patients around the world.
Investment in 2021 ECO Tree Series A Units
- Investment in Eco-Tree program for profits from lumber sales and carbon credits
- Managed by the largest grower of Empress Splendor trees in North America